Cargando…
Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805688/ https://www.ncbi.nlm.nih.gov/pubmed/34962725 http://dx.doi.org/10.1002/clt2.12081 |
| _version_ | 1784643280986701824 |
|---|---|
| author | van der Veer, Tjeerd Dallinga, Marloes A. van der Valk, Johanna P. M. Kappen, Jasper H. in ’t Veen, Johannes C. C. M. van der Eerden, Menno M. Braunstahl, Gert‐Jan |
| author_facet | van der Veer, Tjeerd Dallinga, Marloes A. van der Valk, Johanna P. M. Kappen, Jasper H. in ’t Veen, Johannes C. C. M. van der Eerden, Menno M. Braunstahl, Gert‐Jan |
| author_sort | van der Veer, Tjeerd |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8805688 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88056882022-02-04 Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab van der Veer, Tjeerd Dallinga, Marloes A. van der Valk, Johanna P. M. Kappen, Jasper H. in ’t Veen, Johannes C. C. M. van der Eerden, Menno M. Braunstahl, Gert‐Jan Clin Transl Allergy Letter John Wiley and Sons Inc. 2021-12-03 /pmc/articles/PMC8805688/ /pubmed/34962725 http://dx.doi.org/10.1002/clt2.12081 Text en © 2021 John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter van der Veer, Tjeerd Dallinga, Marloes A. van der Valk, Johanna P. M. Kappen, Jasper H. in ’t Veen, Johannes C. C. M. van der Eerden, Menno M. Braunstahl, Gert‐Jan Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab |
| title | Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab |
| title_full | Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab |
| title_fullStr | Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab |
| title_full_unstemmed | Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab |
| title_short | Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab |
| title_sort | reduced exacerbation frequency and prednisone dose in patients with abpa and asthma treated with dupilumab |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805688/ https://www.ncbi.nlm.nih.gov/pubmed/34962725 http://dx.doi.org/10.1002/clt2.12081 |
| work_keys_str_mv | AT vanderveertjeerd reducedexacerbationfrequencyandprednisonedoseinpatientswithabpaandasthmatreatedwithdupilumab AT dallingamarloesa reducedexacerbationfrequencyandprednisonedoseinpatientswithabpaandasthmatreatedwithdupilumab AT vandervalkjohannapm reducedexacerbationfrequencyandprednisonedoseinpatientswithabpaandasthmatreatedwithdupilumab AT kappenjasperh reducedexacerbationfrequencyandprednisonedoseinpatientswithabpaandasthmatreatedwithdupilumab AT intveenjohannesccm reducedexacerbationfrequencyandprednisonedoseinpatientswithabpaandasthmatreatedwithdupilumab AT vandereerdenmennom reducedexacerbationfrequencyandprednisonedoseinpatientswithabpaandasthmatreatedwithdupilumab AT braunstahlgertjan reducedexacerbationfrequencyandprednisonedoseinpatientswithabpaandasthmatreatedwithdupilumab |